By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development of adult stem cell technology platform for commercialization17.2M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Australia17.2M100.00%